Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Articles

The contract research organization has increased its US-based early phase clinical capacity and doubled its specialty lab space.

QPS Expands US-Based Phase I Clinical Trial Capabilities

Catalent will expand primary packaging capabilities and commission an automated, high-speed bottling line for clinical packaging of capsules and tablets.

Catalent Expands Clinical Packaging Capabilities in Shanghai, China

ADC Biotechnology will invest downstream formulation, fill/finish capabilities, and Lock-Release conjugation technology.

ADC Bio Secures Additional Equity Round Investment

With the $252-million acquisition of contract development, manufacturing, and testing organization Avista Pharma Solutions, Cambrex will enter the market for early stage small-molecule development and testing services.

Cambrex to Acquire Avista Pharma

As biopharma companies rapidly change their focus, they may lack the laboratory space, instrumentation, and the scientific knowledge to support biologics research.

Barriers and Solutions to Effective External Collaboration in Biopharma

Ardena has moved into its expanded headquarters, located in Gent, Belgium, as a result of continued growth.

Ardena Moves to Expanded Headquarters in Belgium

The expansion adds new capabilities and enhances existing service offerings for both oral and parenteral dosage forms.

Lonza Expands Parenteral Dosage Form Capabilities

Ronald A. Rader is senior director, Technical Research, at BioPlan Associates.

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

The growth in adoption of single-use systems for commercial manufacturing will be dramatic in coming years.

Single-Use Bioprocessing Equipment Trends and Adoption by CMOs

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

Survey results and record attendance show positive signs for various bio/pharma regions.

Innovation and Industry Strength Recognized at CPhI

The company will complete an expansion of its secondary packaging capabilities at its Ravensburg, Germany site by 2020.